Tocilizumab and Cytokine Release Syndrome in COVID-19 Pneumonia: Experience From a Single Center in Pakistan.

Hassan, Muhammad; Syed, Fibhaa; Zafar, Maria; Iqbal, Mansoor; Khan, Naveed Ullah; Mushtaq, Hafiza Faiza; Badshah, Mazhar

Hassan, Muhammad; Syed, Fibhaa; Zafar, Maria; Iqbal, Mansoor; Khan, Naveed Ullah; Mushtaq, Hafiza Faiza; Badshah, Mazhar.

Afiliación

Hassan M; Neurology, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Syed F; Internal Medicine, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Zafar M; Internal Medicine, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Iqbal M; Neurology, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Khan NU; Neurology, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Mushtaq HF; Obstetrics and Gynaecology, Shaheed Zulfiqar Ali Bhutto Medical University, Islamabad, PAK.
Badshah M; Neurology, Pakistan Institute of Medical Sciences, Islamabad, PAK.

Cureus ; 13(12): e20219, 2021 Dec.

Article en En | MEDLINE | ID: mdl-35004038

Palabras clave

covid-19; cytokine release syndrome; interleukin-6 (il-6); sars-cov-2; tocilizumab

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Cureus Año: 2021 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google